1. Home
  2. GANX vs GOCO Comparison

GANX vs GOCO Comparison

Compare GANX & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • GOCO
  • Stock Information
  • Founded
  • GANX 2017
  • GOCO 2001
  • Country
  • GANX United States
  • GOCO United States
  • Employees
  • GANX N/A
  • GOCO N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • GOCO Specialty Insurers
  • Sector
  • GANX Health Care
  • GOCO Finance
  • Exchange
  • GANX Nasdaq
  • GOCO Nasdaq
  • Market Cap
  • GANX 69.0M
  • GOCO 64.9M
  • IPO Year
  • GANX 2021
  • GOCO 2020
  • Fundamental
  • Price
  • GANX $1.58
  • GOCO $4.80
  • Analyst Decision
  • GANX Strong Buy
  • GOCO Hold
  • Analyst Count
  • GANX 5
  • GOCO 1
  • Target Price
  • GANX $8.20
  • GOCO $12.00
  • AVG Volume (30 Days)
  • GANX 526.2K
  • GOCO 45.0K
  • Earning Date
  • GANX 11-13-2025
  • GOCO 11-06-2025
  • Dividend Yield
  • GANX N/A
  • GOCO N/A
  • EPS Growth
  • GANX N/A
  • GOCO N/A
  • EPS
  • GANX N/A
  • GOCO N/A
  • Revenue
  • GANX N/A
  • GOCO $822,444,000.00
  • Revenue This Year
  • GANX N/A
  • GOCO $2.06
  • Revenue Next Year
  • GANX N/A
  • GOCO $5.47
  • P/E Ratio
  • GANX N/A
  • GOCO N/A
  • Revenue Growth
  • GANX N/A
  • GOCO 17.46
  • 52 Week Low
  • GANX $1.36
  • GOCO $4.65
  • 52 Week High
  • GANX $3.19
  • GOCO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • GANX 39.85
  • GOCO 38.80
  • Support Level
  • GANX $1.55
  • GOCO $4.76
  • Resistance Level
  • GANX $1.78
  • GOCO $5.01
  • Average True Range (ATR)
  • GANX 0.13
  • GOCO 0.24
  • MACD
  • GANX -0.03
  • GOCO 0.01
  • Stochastic Oscillator
  • GANX 6.00
  • GOCO 18.74

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

Share on Social Networks: